Evidence map›Paper›PMID 37863898›Full record

ArticleNature communications2023

Glycerol-weighted chemical exchange saturation transfer nanoprobes allow

Rong A, Haoyu Wang, Chaoqun Nie, Zhaoguo Han, Meifang Zhou, Olagbaju Oluwatosin Atinuke, Kaiqi Wang, Xiance Wang, Shuang Liu, Jingshi Zhao and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rong A *Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.ORCID 0000-0002-6246-4682
Haoyu Wang *Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Chaoqun Nie *NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China.ORCID 0000-0003-2405-1913
Zhaoguo Han *Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Meifang ZhouDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Olagbaju Oluwatosin AtinukeDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Kaiqi WangDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Xiance WangDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Shuang LiuDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Jingshi ZhaoNHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China.
Wenju QiaoDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Xiaohong SunDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Lina WuDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.
Xilin SunDepartment of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China. sunxl@ems.hrbmu.edu.cn.ORCID 0000-0001-7464-5117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, radiotherapy (RT) has entered a new realm of precision cancer therapy with the introduction of magnetic resonance (MR) imaging guided radiotherapy systems into the clinic. Nonetheless, identifying an optimized radiotherapy time window (ORTW) is still critical for the best therapeutic efficacy of RT. Here we describe pH and O

Indexed as

NeoplasmsProtonsGlycerolHumansHydrogen-Ion ConcentrationMagnetic Resonance ImagingPhantoms, ImagingGlycerolProtons

Identifiers

PMID37863898
PMCPMC10589257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.